Climb Bio Inc. (CLYM)
NASDAQ: CLYM
· Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Oct 03, 2025, 3:59 PM
1.99
0.51%
After-hours: Oct 03, 2025, 07:38 PM EDT
-2.94% (1D)
| Bid | 1.96 |
| Market Cap | 134.17M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -46.76M |
| EPS (ttm) | -0.02 |
| PE Ratio (ttm) | -99 |
| Forward PE | -2.76 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.01 |
| Volume | 1,534,536 |
| Avg. Volume (20D) | 506,179 |
| Open | 2.04 |
| Previous Close | 2.04 |
| Day's Range | 1.97 - 2.12 |
| 52-Week Range | 1.05 - 5.47 |
| Beta | -0.06 |
| Ex-Dividend Date | n/a |
About CLYM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLYM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLYM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+12.1%
Climb Bio shares are trading higher after Oppenhei...
Unlock content with
Pro Subscription
10 months ago
+7.12%
Climb Bio shares are trading higher. The company announced it appointed a new chair to its board of directors.
